Human papillomavirus (HPV) stress

GYN & PERINATAL ZURICH > Human papillomavirus (HPV) stress

Is stress related to the presence and persistence of oncogenic human papillomavirus infection in young women?

Authors: Ulrike Kuebler, Susanne Fischer, Laura Mernone, Christian Breymann, Elvira Abbruzzese and Ulrike Ehlert (2021)

Background:

Persistent high-risk human papillomavirus (HR-HPV) infection is the most important risk factor for the development of cervical cancer, but factors contributing to HR-HPV persistence are incompletely understood. The aim of this study was to test associations of chronic stress and two aspects of daily cortisol secretion (i.e. cortisol awakening response [CAR] and total cortisol production throughout the day [AUCgday]) with HR-HPV status at baseline and 12 months later (follow-up).

Methods:

We studied 188 women (25 ± 3 years) at baseline. Follow-up was restricted to HR-HPV-infected women at baseline. Of the first 48 HR-HPV-positive participants, 42 completed follow-up (16 HR-HPV-positive and 26 HR-HPV-negative). At baseline and follow-up, we determined HR-HPV status in cervical smears, assessed chronic stress and measured salivary cortisol repeatedly throughout the day. At baseline, we analysed salivary cortisol only in a subgroup of 90 participants (45 HR-HPV negative and 45 HR-HPV positive).

Results:

At baseline, higher chronic stress (excessive demands at work: p = 0.022, chronic worry: p = 0.032) and higher CAR (p = 0.014) were associated with HR-HPV positivity at baseline. At follow-up, there was a statistical trend for a positive association between CAR and HR-HPV positivity (p = 0.062). Neither CAR nor AUCgday mediated the associations between chronic stress and HR-HPV status.

Conclusions:

Our results suggest that both chronic stress and daily cortisol are associated with the presence of HR-HPV infection and may therefore play a role in HPV-associated cervical carcinogenesis.

Cholestasis during pregnancy (Gentics)

April 20, 2023

Intrahepatic cholestasis of pregnancy (ICP) or pregnancy cholestasis is a liver disease that occurs in some women in late pregnancy. It manifests as severe itching, but without a visible rash. ICP can cause a temporary decrease in liver function in pregnant women,...

Read more

Pharmacogenetics and individual drug metabolism in pregnancy.

April 15, 2023

During the first three months of pregnancy, about 80% of women take at least one medication. Nearly 30% of expectant mothers consume four or more medications during this period, both prescription and over-the-counter (not including vitamins or iron)....

Read more

Infertility in folic acid metabolism disorders: genetics (MTHFR)

April 10, 2023

A healthy life already begins with development in the womb. In Switzerland, about 50 to 60 children or embryos suffer from a severe spinal cord malformation, known as "open back" or "spina bifida", in the first weeks of pregnancy every year. Folic acid, a...

Read more